Diabetes

Addition of sotagliflozin for T1DM alters renal hemodynamics

(HealthDay)—Sotagliflozin (SOTA), a dual sodium-glucose cotransporter 1 inhibitor (SGLT1i) and SGLT2i, is associated with short- and long-term renal hemodynamic changes in patients with type 1 diabetes, according to a study ...

Diseases, Conditions, Syndromes

New hope for cirrhosis of the liver

Decompensated cirrhosis is a chronic disease linked to numerous complications in its final stage. Professor Jonel Trebicka from Goethe University was involved in carrying out a pilot study demonstrating that the long-term ...

Health

No pain, no gain? It's not the way.

An innovative team at UWA have taken a decades-old test and transformed it, helping athletes avoid overtraining and injury.

Diseases, Conditions, Syndromes

Predictors of infliximab response in ulcerative colitis identified

(HealthDay)—For patients with acute severe ulcerative colitis (ASUC), the baseline Mayo Endoscopic Score and the C-reactive protein (CRP)/albumin ratio predict treatment response to infliximab, according to research published ...

Cardiology

Adding albumin to risk score improves mortality prediction

(HealthDay)—Serum albumin, as a marker of frailty, can significantly improve the ability of the Society of Thoracic Surgeons (STS) and European System for Cardiac Operative Risk Evaluation (EuroSCORE-2) scores to predict ...

page 3 from 6